Skip to main content
Top

Preventive Health Services in Reproductive-Aged Women with Diabetes Mellitus: A Scoping Review

Abstract

Background

Diabetes mellitus (DM), both type 1 (T1DM) and type 2 (T2DM), complicates about 1% of pregnancies in the US. Current research frequently focuses on the effects of DM on pregnancy outcomes, overlooking the opportunity to examine a woman’s health prior to pregnancy despite the significance of pre-conception health on pregnancy outcomes.

Methods

Recognizing the importance of a woman’s overall health, and not just the period in which a woman is pregnant, we set out to explore whether women with DM received recommended preventive health services at the same rates as women without DM. PubMed, Web of Science Core Collection, and Cochrane Library of Systematic Reviews and Trials were searched using search terms related to four areas of preventive health services for women with T1DM or T2DM: contraceptive counseling, age-appropriate cancer screening, pre-conception counseling, and recommended sexually transmitted infection (STI) screening.

Results

Most studies confirmed that women with DM consistently received less contraception management or contraception counseling compared to women without DM. Women with DM also had lower rates of breast and cervical cancer screening. Studies of pre-conception counseling suggest low rates of counseling provided to women with DM. No studies comparing STI screening rates between women with and without DM could even be identified. We also identified a paucity of evidence-based interventions directed at expanding the provision of these preventive services to women with DM.

Discussion

Differences exist in the provision of recommended preventive health services between women with and without DM, and there are also research gaps regarding well-woman preventive care in women with DM.

Registry

Open Science Framework—https://doi.org/10.17605/OSF.IO/3MV6Q
Title
Preventive Health Services in Reproductive-Aged Women with Diabetes Mellitus: A Scoping Review
Authors
Madeline L. Treasure, MD
Pourandokht S. Nourbakhsh, MD
Kate Diaz Roldan, MPH
Antonia Osuna-Garcia, MLIS
Sara C. Esteves, BS
Lisa N. Kransdorf, MD, MPH
Lauren E. Wisk, PhD
Publication date
02-04-2026
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-026-10253-5
This content is only visible if you are logged in and have the appropriate permissions.
This content is only visible if you are logged in and have the appropriate permissions.
SPONSORED

Adherence to injectables

In this podcast, Professor Jorge Sánchez shares his insights into identifying and addressing poor adherence to injectable therapy, offering guidance that can help to support patients with chronic diseases through their treatment journey.

Sponsor:
  • Novartis Pharma AG
Prof. Jorge Sánchez
Listen now
Podcast

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Adis Journal Podcast/© Adis, Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images